183 related articles for article (PubMed ID: 19280349)
21. Preparation and Biophysical Characterization of Quercetin Inclusion Complexes with β-Cyclodextrin Derivatives to be Formulated as Possible Nose-to-Brain Quercetin Delivery Systems.
Manta K; Papakyriakopoulou P; Chountoulesi M; Diamantis DA; Spaneas D; Vakali V; Naziris N; Chatziathanasiadou MV; Andreadelis I; Moschovou K; Athanasiadou I; Dallas P; Rekkas DM; Demetzos C; Colombo G; Banella S; Javornik U; Plavec J; Mavromoustakos T; Tzakos AG; Valsami G
Mol Pharm; 2020 Nov; 17(11):4241-4255. PubMed ID: 32986435
[TBL] [Abstract][Full Text] [Related]
22. Improvement of dissolution properties of furosemide by complexation with beta-cyclodextrin.
Ozdemir N; Ordu S
Drug Dev Ind Pharm; 1998 Jan; 24(1):19-25. PubMed ID: 15605593
[TBL] [Abstract][Full Text] [Related]
23. Improvement in solubility and dissolution rate of 1, 2-dithiole-3-thiones upon complexation with beta-cyclodextrin and its hydroxypropyl and sulfobutyl ether-7 derivatives.
Dollo G; Le Corre P; Chollet M; Chevanne F; Bertault M; Burgot JL; Le Verge R
J Pharm Sci; 1999 Sep; 88(9):889-95. PubMed ID: 10479350
[TBL] [Abstract][Full Text] [Related]
24. Rofecoxib-beta-cyclodextrin inclusion complex for solubility enhancement.
Rawat S; Jain SK
Pharmazie; 2003 Sep; 58(9):639-41. PubMed ID: 14531460
[TBL] [Abstract][Full Text] [Related]
25. Physicochemical and structural characterization of quercetin-beta-cyclodextrin complexes.
Zheng Y; Haworth IS; Zuo Z; Chow MS; Chow AH
J Pharm Sci; 2005 May; 94(5):1079-89. PubMed ID: 15793810
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and characterization of a new cyclodextrin derivative with improved properties to design oral dosage forms.
García A; Priotti J; Codina AV; Vasconi MD; Quiroga AD; Hinrichsen LI; Leonardi D; Lamas MC
Drug Deliv Transl Res; 2019 Feb; 9(1):273-283. PubMed ID: 30264285
[TBL] [Abstract][Full Text] [Related]
27. Improved Aqueous Solubility and Antihypercholesterolemic Activity of Ezetimibe on Formulating with Hydroxypropyl-β-Cyclodextrin and Hydrophilic Auxiliary Substances.
Srivalli KM; Mishra B
AAPS PharmSciTech; 2016 Apr; 17(2):272-83. PubMed ID: 26077622
[TBL] [Abstract][Full Text] [Related]
28. In vitro and in vivo evaluation of an amylobarbitone/hydroxypropyl-beta-cyclodextrin complex prepared by a freeze-drying method.
Fathy M; Sheha M
Pharmazie; 2000 Jul; 55(7):513-7. PubMed ID: 10944779
[TBL] [Abstract][Full Text] [Related]
29. Formulation and development of extended-release micro particulate drug delivery system of solubilized rifaximin.
Karanje RV; Bhavsar YV; Jahagirdar KH; Bhise KS
AAPS PharmSciTech; 2013 Jun; 14(2):639-48. PubMed ID: 23516110
[TBL] [Abstract][Full Text] [Related]
30. Piroxicam/2-hydroxypropyl-beta-cyclodextrin inclusion complex prepared by a new fluid-bed coating technique.
Zhang X; Wu D; Lai J; Lu Y; Yin Z; Wu W
J Pharm Sci; 2009 Feb; 98(2):665-75. PubMed ID: 18543294
[TBL] [Abstract][Full Text] [Related]
31. Study of freeze-dried quercetin-cyclodextrin binary systems by DSC, FT-IR, X-ray diffraction and SEM analysis.
Pralhad T; Rajendrakumar K
J Pharm Biomed Anal; 2004 Feb; 34(2):333-9. PubMed ID: 15013147
[TBL] [Abstract][Full Text] [Related]
32. Optimization of a method for preparing solid complexes of essential clove oil with β-cyclodextrins.
Hernández-Sánchez P; López-Miranda S; Guardiola L; Serrano-Martínez A; Gabaldón JA; Nuñez-Delicado E
J Sci Food Agric; 2017 Jan; 97(2):420-426. PubMed ID: 27133126
[TBL] [Abstract][Full Text] [Related]
33. Complexation of ursodeoxycholic acid with beta-cyclodextrin-choline dichloride coprecipitate.
Orienti I; Cerchiara T; Zecchi V; Arias Blanco MJ; Gines JM; Moyano JR; Rabasco Alvarez AM
Int J Pharm; 1999 Nov; 190(2):139-53. PubMed ID: 10547454
[TBL] [Abstract][Full Text] [Related]
34. Docetaxel/dimethyl-β-cyclodextrin inclusion complexes: preparation,
Giri BR; Lee J; Lim DY; Kim DW
Drug Dev Ind Pharm; 2021 Feb; 47(2):319-328. PubMed ID: 33576707
[TBL] [Abstract][Full Text] [Related]
35. Effect of the hydrophobic nature of triacetyl-beta-cyclodextrin on the complexation with nicardipine hydrochloride: physicochemical and dissolution properties of the kneaded and spray-dried complexes.
Fernandes CM; Veiga FJ
Chem Pharm Bull (Tokyo); 2002 Dec; 50(12):1597-602. PubMed ID: 12499598
[TBL] [Abstract][Full Text] [Related]
36. Cyclodextrin inclusion complex of racecadotril: effect of drug-β- cyclodextrin ratio and the method of complexation.
Semalty M; Panchpuri M; Singh D; Semalty A
Curr Drug Discov Technol; 2014 Jun; 11(2):154-61. PubMed ID: 24188445
[TBL] [Abstract][Full Text] [Related]
37. Dissolution properties and characterization of halofantrine-2-hydroxypropyl-beta-cyclodextrin binary systems.
Onyeji CO; Omoruyi SI; Oladimeji FA
Pharmazie; 2007 Nov; 62(11):858-63. PubMed ID: 18065103
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and spectral investigation of Al(III) catechin/beta-cyclodextrin and Al(III) quercetin/beta-cyclodextrin inclusion compounds.
Dias K; Nikolaou S; De Giovani WF
Spectrochim Acta A Mol Biomol Spectrosc; 2008 Jun; 70(1):154-61. PubMed ID: 18054838
[TBL] [Abstract][Full Text] [Related]
39. Physicochemical characteristics and bioavailability of a novel intestinal metabolite of ginseng saponin (IH901) complexed with beta-cyclodextrin.
Lee PS; Han JY; Song TW; Sung JH; Kwon OS; Song S; Chung YB
Int J Pharm; 2006 Jun; 316(1-2):29-36. PubMed ID: 16574357
[TBL] [Abstract][Full Text] [Related]
40. Sulfobutyl ether(7) β-cyclodextrin (SBE(7) β-CD) carbamazepine complex: preparation, characterization, molecular modeling, and evaluation of in vivo anti-epileptic activity.
Jain AS; Date AA; Pissurlenkar RR; Coutinho EC; Nagarsenker MS
AAPS PharmSciTech; 2011 Dec; 12(4):1163-75. PubMed ID: 21918921
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
